ROIV
Roivant Sciences Ltd.
NASDAQ · Healthcare · Biotechnology · GB
$34.93
+1.51%Leverage
- Debt / equity
- 0.03x
- Net debt / equity
- -0.27x
- Debt / assets
- 0.02x
- Debt / EBITDA
- -0.38x
- Net debt / EBITDA
- 4.06x
Liquidity & coverage
- Current ratio
- 16.72x
- Quick ratio
- 16.72x
- Cash ratio
- 13.55x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $4.5B
Cash & dividend
- FCF / debt
- -7.60x
- Cash flow / debt
- -7.55x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026